Elisa De La Cruz

6PUBLICATIONS
33CO-AUTHORS
Neurology and neuromuscular diseasesImmunogenetics (incl. genetic immunology)Cancer diagnosisDevelopmental genetics (incl. sex determination)Cardiovascular medicine and haematology not elsewhere classified
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Feb 26, 2025
Comparative Performances of 4 Serum NfL Assays, pTau181, and GFAP in Patients With Amyotrophic Lateral Sclerosis.

Etienne Mondesert, Constance Delaby, Elisa De La Cruz

|Oct 24, 2024
MYH7-related myopathies: clinical, myopathological and genotypic spectrum in a multicentre French cohort.

Marie Bahout, Gianmarco Severa, Emna Kamoun

|Jul 02, 2024
Author Correction: The SOD1-mediated ALS phenotype shows a decoupling between age of symptom onset and disease duration.

Sarah Opie-Martin, Alfredo Iacoangeli, Simon D Topp

|Jun 26, 2024
Most SOD1 mutations are pathogenic, and their identification can lead to early access to treatment.

Elisa De La Cruz, Florence Esselin, Anne Polge

|Nov 13, 2022
The SOD1-mediated ALS phenotype shows a decoupling between age of symptom onset and disease duration.

Sarah Opie-Martin, Alfredo Iacoangeli, Simon D Topp

|Dec 17, 2020
A rare cause of midbrain haemorrhage.

Kristin S Lange, Guillaume Taieb, Pierre Lepretre

Pageof 1